|End-of-day quote - 01/20|
Tot Biopharm International Company Limited Reports Unaudited Consolidated Earnings Results for the Period Nine Months from January 1, 2020 to September 30, 202011/11/2020 | 08:02am
TOT BIOPHARM International Company Limited reported Unaudited consolidated earnings results for the period nine months from January 1, 2020 to September 30, 2020. For the period the company reported Operating revenue was RMB 18,447,000. Net loss was RMB 211,080,000.
© S&P Capital IQ 2022
All news about TOT BIOPHARM INTERNATIONAL COMPANY LIMITED